Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong · Delayed Price · Currency is HKD 7.42
+0.02 (0.27%)
Oct 22, 2025, 4:08 PM HKT
HKG:0719 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 428.38 | 470.02 | 496.51 | 411.06 | 348.55 | 324.86 | Upgrade |
Depreciation & Amortization | 555.86 | 540.95 | 516.94 | 489.4 | 438.58 | 385.39 | Upgrade |
Other Amortization | 6.31 | 4.73 | 3.32 | 2.75 | 2.48 | 0.41 | Upgrade |
Loss (Gain) From Sale of Assets | -1.89 | -1.42 | -8.73 | -5.54 | -2.07 | -2.49 | Upgrade |
Asset Writedown & Restructuring Costs | 56.18 | 5.12 | -33.26 | -39.29 | -84.79 | -72.22 | Upgrade |
Loss (Gain) From Sale of Investments | -6.2 | -9.84 | -9.58 | -8.36 | -8.02 | -5.61 | Upgrade |
Provision & Write-off of Bad Debts | 9.12 | 8.49 | 10.73 | 5.24 | 2.32 | 0.3 | Upgrade |
Other Operating Activities | 122.07 | 110.12 | 121.24 | 122.37 | 97.65 | 144.06 | Upgrade |
Change in Accounts Receivable | -440.07 | -629.94 | -423.54 | -717.33 | -751.07 | -683.31 | Upgrade |
Change in Inventory | -143.29 | -11.43 | -120.86 | -200.14 | 76.18 | 37.48 | Upgrade |
Change in Accounts Payable | -74.31 | -153.63 | -332.39 | 632.33 | 121.63 | 260.2 | Upgrade |
Change in Other Net Operating Assets | 26.79 | 35.88 | 53.07 | 45.8 | 3.96 | 8.28 | Upgrade |
Operating Cash Flow | 524.34 | 367.61 | 265.28 | 758.24 | 259.12 | 420.19 | Upgrade |
Operating Cash Flow Growth | 62.56% | 38.57% | -65.01% | 192.63% | -38.33% | 20.65% | Upgrade |
Capital Expenditures | -192.08 | -212.42 | -325.13 | -244.76 | -249.23 | -280.19 | Upgrade |
Sale of Property, Plant & Equipment | 0.58 | 0.65 | 11.86 | 7.94 | 2.43 | 3.59 | Upgrade |
Investment in Securities | -11.61 | -8.63 | - | - | - | -30 | Upgrade |
Other Investing Activities | 11.3 | 8.18 | 8.17 | 7.92 | 9.11 | 8.59 | Upgrade |
Investing Cash Flow | -191.82 | -212.21 | -305.11 | -228.9 | -237.69 | -298 | Upgrade |
Long-Term Debt Issued | - | 860.31 | 862.43 | 833.79 | 551.41 | 1,045 | Upgrade |
Long-Term Debt Repaid | - | -554.05 | -888.15 | -1,106 | -603.48 | -902.34 | Upgrade |
Net Debt Issued (Repaid) | 98.33 | 306.26 | -25.72 | -272.57 | -52.07 | 142.23 | Upgrade |
Issuance of Common Stock | 60.05 | 63.26 | 6.02 | 274.69 | 32.97 | 19 | Upgrade |
Common Dividends Paid | -229.58 | -225.85 | -175.9 | -163.01 | -148.43 | -126.85 | Upgrade |
Other Financing Activities | 42.6 | 41.11 | -0.5 | 30.24 | 27.8 | 0.65 | Upgrade |
Financing Cash Flow | -28.59 | 184.78 | -196.11 | -130.66 | -139.73 | 35.04 | Upgrade |
Foreign Exchange Rate Adjustments | 8.98 | 15.01 | 6.86 | 15.69 | -7.87 | -12.28 | Upgrade |
Net Cash Flow | 312.91 | 355.19 | -229.08 | 414.37 | -126.17 | 144.94 | Upgrade |
Free Cash Flow | 332.26 | 155.19 | -59.85 | 513.48 | 9.89 | 140 | Upgrade |
Free Cash Flow Growth | 1547.30% | - | - | 5092.02% | -92.94% | - | Upgrade |
Free Cash Flow Margin | 3.97% | 1.83% | -0.74% | 6.84% | 0.15% | 2.33% | Upgrade |
Free Cash Flow Per Share | 0.48 | 0.23 | -0.09 | 0.77 | 0.02 | 0.22 | Upgrade |
Cash Income Tax Paid | 83.08 | 96.2 | 239.79 | 66.25 | 44.5 | 118.26 | Upgrade |
Levered Free Cash Flow | 653.93 | 551.12 | 50.07 | 779.34 | 222.79 | 496.09 | Upgrade |
Unlevered Free Cash Flow | 681 | 575.96 | 75.79 | 810.41 | 255.98 | 533.44 | Upgrade |
Change in Working Capital | -645.48 | -760.56 | -831.87 | -219.39 | -535.59 | -354.51 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.